MedPath

Fasciolosis treatment with Egate

Phase 2
Recruiting
Conditions
Fasciolosis
Registration Number
JPRN-jRCTs071190020
Lead Sponsor
Maruyama Haruhiko
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
33
Inclusion Criteria

1) Patients who are diagnosed as having fasciolosis
2) Patients who give written informed consent
3) Informed consent from proxies are obtained

Exclusion Criteria

1) Patients who are allergic to Triclabendazole
2) Patients who are pregnant, or possibly pregnant
3) Patients who does not give written informed consent
4) Patients principal investigator judged inappropriate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath